Immunohistochemical detection of Bcl-2 in AIDS-associated and classical Kaposi's sarcoma

American Journal of Pathology

Volumn 148, Issue 4, 1996, Pages 1055-1063

  Morris, C Bohan ^a   Gendelman, R ^b   Marrogi, A J ^a   Lu, M ^a   Lockyer, J M ^a   Alperin Lea, W ^a   Ensoli, B ^b  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; CYTOKINE; TRANSACTIVATOR PROTEIN; ONCOPROTEIN; PROTEIN BCL 2;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; APOPTOSIS; ARTICLE; CELL VIABILITY; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPOSI SARCOMA; MALE; PRIORITY JOURNAL; PROTO ONCOGENE; SPINDLE CELL; VASCULAR ENDOTHELIUM; ADOLESCENT; AGED; CHEMISTRY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; FACTOR VIII; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SARCOMA, KAPOSI;

EID: 0029665495     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Friedman-Kien AE: Disseminated Kaposi's sarcoma syndrome in young homosexual men. J Am Acad Dermatol 1981, 5:468-471
2. Gottlieb GJ, Ackerman AB. Kaposi's sarcoma: an extensively disseminated focus in young homosexual men Hum Pathol 1982, 13 882-892
3. Haverkos HW, Drotman DP, Morgan M: Prevalence of Kaposi's sarcoma among patients with AIDS N Engl J Med 1985, 312 1518
4. Levine AM: AIDS-related malignancies: the emerging epidemic. J Natl Cancer Inst 1993, 85.1382-1397
5. Ensoli B, Barillari G, Gallo RC Pathogenesis of AIDS-associated Kaposi's sarcoma Hematol Oncol Aspects HIV Dis 1991, 5 281-295
6. Ensoli B, Gallo RC: Growth factors in AIDS-associated Kaposi's sarcoma, cytokines and HIV-1 Tat protein AIDS Updates 1994, 7:1-12
7. Buonaguro L, Barillari G, Chang HK, Bohan CA, Kao V. Morgan R, Gallo RC, Ensoli B: Effects of human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines. J Virol 1992, 66:7159-7167
8. Barillari G, Buonaguro L, Fiorelli V, Hoffman J, Michaels F, Gallo RC, Ensoli B. Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. J Immunol 1992, 149:3727-3734
9. Miles SA, Rezai AR, Salazar-Gonzalez JF, VanderMeyden M, Stevens RH, Logan DM, Mitsuyasu RT, Taga T, Hirano T, Kishimoto T, Martinez-Maza O: AIDS Kaposi's sarcoma-derived cells produce and respond to interleukin 6 Proc Natl Acad Sci USA 1990, 87.4068-4072
10. Fiorelli V, Gendelman R, Samaniego F, Markham PD, Ensoli B: Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells J Clin Invest 1995, 95:1723-1734
11. Ensoli B, Barillari G, Salahuddin SZ, Gallo RC, Wong-Staal F. Tat protein of HIV-1 stimulates growth of AIDS-Kaposi's sarcoma-derived cells Nature 1990, 345: 84-86
12. Mann DA, Frankel, AD: Endocytosis and targeting of exogenous HIV-1 Tat protein EMBO J 1991, 10.1733-1739
13. Ensoli B, Buonaguro L, Barillari G, Fiorelli V, Gendelman R, Morgan RA, Gallo RC: Release, uptake and effect of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J Virol 1993, 67:277-287
14. Barillari G, Gendelman R, Gallo RC, Ensoli B: The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi's sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell type by using integrin receptors recognizing the RGD ammo acid sequence. Proc Natl Acad Sci USA 1993, 90:7941-7945
15. Ensoli B, Nakamura S, Salahuddin SZ, Biberfeld P, Larsson L, Beaver B, Wong-Staal F, Gallo RC: AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science 1990, 243:223-226
16. Ensoli B, Gendelman R, Markham P, Fiorelli V, Colombini S, Raffeld M, Cafaro A, Chang H-K, Brady JN, Gallo RC. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma Nature 1994, 371.674-680
17. Donehower LA, Bradley A: The tumor suppressor p53 Biochim Biophys Acta 1993, 1155:181-205
18. Zambetti GP, Levine AJ: A comparison of the biological activities of wild-type and mutant p53. FASEB J 1993, 7:855-865
19. Chiou SK, Rao L, White E: Bcl-2 blocks p53-dependent apoptosis Mol Cell Biol 1994, 14.2556-2563
20. Debbas M, White, E. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes & Dev 1993, 7:546-554
21. Lowe SW, Ruley HE: Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis Genes & Dev 1993, 7.535-545
22. Wang XW, Forrester K, Yeh H, Feitelson MA, Gu JR and Harris CC: Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc Natl Acad Sci USA 1994, 91:2230-2234
23. Szekely L, Selivanova G, Magnusson KP. Klein G, Wiman KG: EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 protein. Proc Natl Acad Sci USA 1993, 90:5455-5459
24. Nunez G, London L, Hockenberry D, Alexander M, McKearn JP, Korsmeyer, SJ: Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived homopoietic cell lines. J Immunol 1990, 9.3602-3610
25. Hockenberry D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death Nature 1990, 348 334-336
26. Strasser A, Harris AW, Cory S. Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 1991, 67:889-899
27. Wang Y, Szekely L, Okan I, Klein G, Wiman KG: Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma line. Oncogene 1993, 8:3427-3431
28. Oren M: p53 the ultimate tumor suppressor gene? FASEB J 1992, 6:3169-3176
29. Vogelstein B, Kinzler KW: p53 function and dysfunction Cell 1992, 70 523-526
30. Hockenberry D, Zutter M, Hickey W, Nahm M, Korsmeyer S: Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death Proc Natl Acad Sci USA 1991, 88 6961-6965
31. El-Habashi A, El-Morsi B, Freeman SM, El-Didi M, Marrogi, AJ: Tumor oncogenic expression in malignant effusions as a possible method to enhance cytologic diagnostic sensitivity Am J Clin Pathol 1995, 103.206-214
32. Hsu SM, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody PAP procedures J Histochem 1981, 29:577-580
33. Chor PJ, Santa Cruz DJ Kaposi's sarcoma. A clinico-pathologic review and differential diagnosis J Cutaneous Pathol 1992, 19:6-20
34. Regezi JA, MacPhail LA, Daniels TE, De Souza YG, Greenspan JS, Greenspan D: Human immunodeficiency virus-associated oral Kaposi's sarcoma: heterogeneous cell population dominated by spindle-shaped endothelial cells Am J Pathol 1993, 143:240-249
35. Lunardi-Iskandar Y, Gill P, Lam V, Zeman RA, Michaels F, Mann DL, Reitz MS Jr., Kaplan M, Berneman ZN, Carter D, Bryant JL, Gallo RC. Isolation and characterization of an immortal neoplastic cell line (KS Y-1) from AIDS-associated Kaposi's sarcoma: JNCI 1995, 87: 974-981
36. Zauli G, Gibellini D, Milani D, Mazzoni M, Borgatti P, La Placa M, Capitani S Human immunodeficiency virus type 1 Tat protein protects lymphoid, epithelial, and neuronal cell lines from death by apoptosis. Cancer Res 1993, 5:4481-4484
37. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper, J, Knowles DM, Moore PS: Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma Science 1994, 266:1865-1869
38. Geiger KD, Gurushanthaiah D, Howes EL, Lewandowski GA, Reed JC, Bloom FG, Sarvetnick NE Cytokine-mediated survival from lethal herpes simplex virus infection. role of programmed neuronal death. Proc Natl Acad Sci USA 1995, 92.3411-3415
39. Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, Longnecker R, Kieff E, Rickinson A: Induction of bcl-2 by Epstein-Barr Virus Latent Membrane Protein 1 protects infected B cells from programmed cell death Cell 1991, 65:1107-1115